Evidence-Based Alternative, ‘Slanted Eyes’ and Electric Circuits: Doing Chinese Medicine in the Post/Socialist Czech Republic

2018 ◽  
pp. 33-58 ◽  
Author(s):  
Tereza Stöckelová ◽  
Jaroslav Klepal
Keyword(s):  
Czech Republic ◽  
Chinese Medicine ◽  
Evidence Based ◽  
Electric Circuits

Evidence-based Clinical Chinese Medicine

10.1142/12306 ◽  
2021 ◽  
Author(s):  
Charlie Changli Xue ◽  
Chuanjian Lu ◽  
Brian H May ◽  
Yihong Liu
Keyword(s):  
Chinese Medicine ◽  
Evidence Based

scholarly journals Evidence-Based Chinese Medicine for Hypertension

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Jie Wang ◽  
Xingjiang Xiong
Keyword(s):  
Chinese Medicine ◽  
Tai Chi ◽  
Clinical Evidence ◽  
Poor Quality ◽  
Evidence Based ◽  
Hypertensive Patients ◽  
Primary Endpoints ◽  
Potential Benefits ◽  
Public Health Challenge

Hypertension is an important worldwide public -health challenge with high mortality and disability. Due to the limitations and concerns with current available hypertension treatments, many hypertensive patients, especially in Asia, have turned to Chinese medicine (CM). Although hypertension is not a CM term, physicians who practice CM in China attempt to treat the disease using CM principles. A variety of approaches for treating hypertension have been taken in CM. For seeking the best evidence of CM in making decisions for hypertensive patients, a number of clinical studies have been conducted in China, which has paved the evidence-based way. After literature searching and analyzing, it appeared that CM was effective for hypertension in clinical use, such as Chinese herbal medicine, acupuncture, moxibustion, cupping, qigong, and Tai Chi. However, due to the poor quality of primary studies, clinical evidence is still weak. The potential benefits and safety of CM for hypertension still need to be confirmed in the future with well-designed RCTs of more persuasive primary endpoints and high-quality SRs. Evidence-based Chinese medicine for hypertension still has a long way to go.

scholarly journals From Prejudice to Evidence: The Case of Rhizoma Coptidis in Singapore

2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Chin Ee Ho ◽  
You Li Goh ◽  
Chang Zhang
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
G6pd Deficiency ◽  
Neonatal Jaundice ◽  
Therapeutic Effects ◽  
Evidence Based ◽  
Rhizoma Coptidis ◽  
History Of ◽  
Hepatoprotective Effects ◽  
Glucose 6 Phosphate Dehydrogenase

Rhizoma Coptidis (RC), commonly known ashuanglian, is a herb frequently used in Traditional Chinese Medicine (TCM) prescriptions. Known to have “clearing damp-heat, quenching fire and counteracting poison” properties, it was widely used in the Chinese community in Singapore. Berberine, an alkaloid isolated from RC, is known to have a wide array of therapeutic effects including antimicrobial, antineoplastic, and hepatoprotective effects. In 1978, RC was implicated in causing neonatal jaundice (NNJ) and kernicterus in neonates suffering from glucose-6-phosphate dehydrogenase (G6PD) deficiency, leading to the banning of RC and berberine in Singapore. More than three decades later, accumulating evidence-based studies pointing to the safety of RC for general public and better understanding of G6PD deficiency, the Health Sciences Authority (HSA) in Singapore reviewed and lifted the prohibition on RC and berberine, turning a brand new chapter in the history of TCM in Singapore. This paper aims to review the safety of RC and berberine, using the prohibition of use and subsequent lifting of ban on RC and berberine in Singapore as an illustration to highlight the importance of evidence-based studies in Traditional Chinese Medicine (TCM).

scholarly journals Enhanced Evidence-Based Chinese Medicine Clinical Practice Guidelines in Hong Kong: A Study Protocol for Three Common Diseases

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Nannan Shi ◽  
Linda L. D. Zhong ◽  
XueJie Han ◽  
Tat Chi Ziea ◽  
Bacon Ng ◽  
...  
Keyword(s):  
Hong Kong ◽  
Clinical Practice ◽  
Chinese Medicine ◽  
Text Mining ◽  
Cerebral Infarction ◽  
Study Protocol ◽  
Chronic Gastritis ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Evidence Based

We presented a study protocol of developing Chinese medicine clinical practice guidelines for three common diseases in Hong Kong, including insomnia, chronic gastritis, and cerebral infarction. This research project will be conducted in three phases. First phase is the preparation stage which consists of the establishment of steering committee and panel. Second phase involves 6 steps, which are searching and identifying evidence, text mining process, Delphi survey, synthesizing of data, consensus conference, and drafting guidelines. In this phase, text mining technique, evidence-based method, and formal consensus method are combined to get consolidated supporting data as the source of CM CPGs. The final phase comprised external reviews, dissemination, and updating. The outputs from this project will provide three CM CPGs for insomnia, chronic gastritis, and cerebral infarction for Hong Kong local use.

Evidence-based Clinical Chinese Medicine

10.1142/11661 ◽  
2020 ◽  
Author(s):  
Charlie Changli Xue ◽  
Chuanjian Lu ◽  
Brian H May ◽  
Yihong Liu
Keyword(s):  
Chinese Medicine ◽  
Evidence Based

Evidence-based Clinical Chinese Medicine

10.1142/11650 ◽  
2020 ◽  
Author(s):  
Charlie Changli Xue ◽  
Chuanjian Lu ◽  
Claire Shuiqing Zhang ◽  
Shaonan Liu
Keyword(s):  
Chinese Medicine ◽  
Evidence Based
Sign in / Sign up

Export Citation Format

Share Document